🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...
Status
Unknown
Location
Cancer institute
Start Date
2016-12
Trial ID
NCT03123770
Treatments Being Tested
This is an open phase II multicentre study evaluating the efficacy and safe...
Status
Completed
Location
Jeroen Bosch Ziekenhuis
Start Date
2006-05
Trial ID
NCT00377559
Treatments Being Tested
The regimen PLD plus cyclophosphamide 4 cycles followed by paclitaxel or do...
Status
Unknown
Location
First Hospital of Jilin University
Start Date
2016-11
Trial ID
NCT02953184
This is an open phase II study evaluating the efficacy and safety of the no...
Status
Terminated
Location
Ziekenhuis Rijnstate
Start Date
2006-08
Trial ID
NCT00377780
Treatments Being Tested
The HER2 status in breast cancer patients may change during the course of t...
Status
Completed
Location
University Hospital Ulm
Start Date
2012-02
Trial ID
NCT01619111
Treatments Being Tested
The OnPrime study is a multi-center, randomized open-label phase 3 study ev...
Status
Recruiting
Location
The University of South Alabama, Mitchell Cancer Institute
Start Date
2022-08-31
Trial ID
NCT05281471
The purpose of the study is to evaluate the benefit of adjuvant chemotherap...
Status
Completed
Location
Clinique du Sud Luxembourg
Start Date
2012-04-12
Trial ID
NCT01564056
Treatments Being Tested
Multicenter randomised phase II study of neoadjuvant therapy in HER2 positi...
Status
Completed
Location
Paracelsus Medical University Salzburg-Oncology, Coop. Group
Start Date
2011-06
Trial ID
NCT01367028
We plan to carry out a prospective, randomized, open phase III clinical tri...
Status
Unknown
Location
Jin Zhang
Start Date
2017-12
Trial ID
NCT03359694